C12Y 402/01002
Fumarate hydratase
Official title: Fumarate hydratase (4.2.1.2)
C12Y402/01002 (Fumarate hydratase) appears on 23 US grants and 39 published applications in this corpus.
Search patents in C12Y- Granted patents
- 23
- Published applications
- 39
- Assignees
- 27
- Inventors
- 67
- Latest grant
- 1 Oct 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2011 | 0 | 2 |
| 2012 | 0 | 0 |
| 2013 | 0 | 2 |
| 2014 | 1 | 4 |
| 2015 | 2 | 5 |
| 2016 | 1 | 1 |
| 2017 | 4 | 6 |
| 2018 | 1 | 5 |
| 2019 | 3 | 1 |
| 2020 | 2 | 3 |
| 2021 | 2 | 1 |
| 2022 | 2 | 2 |
| 2023 | 2 | 3 |
| 2024 | 3 | 2 |
| 2025 | 0 | 1 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Production of 4,6-dihydroxy-2-oxo-hexanoic acid1 Oct 2024US 12,104,160 B2Zymochem, Inc.
- Construction and application of engineered strain of Escherichia coli for producing malic acid by fixing CO230 Jul 2024US 12,049,661 B2Jiangnan University
- Bioconversion of short-chain hydrocarbons to fuels and chemicals27 Feb 2024US 11,913,049 B2
- Yeast cells having reductive TCA pathway from pyruvate to succinate and overexpressing an exogenous NAD(P+) transhydrogenase enzyme21 Nov 2023US 11,821,021 B2Cargill, Incorporated
- Method AMD strains for reducing byproduct fumaric acid in fermentation process of L-malic acid and use thereof22 Aug 2023US 11,732,279 B2
- New ethylenediamine-n,n'-disuccinic acid (edds) synthases23 Jul 2026US 2026/0209807 A1BASF SE
- Acid-resistant yeast strain for efficient production of succinic acid, and construction method therefor and use thereof23 Jan 2025US 2025/0027120 A1Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences
- Bioconversion of Short-Chain Hydrocarbons to Fuels and Chemicals19 Sep 2024US 2024/0309417 A1
- Yeast cells having reductive tca pathway from pyruvate to succinate and overexpressing an exogenous nad(p+) transhydrogenase enzyme15 Feb 2024US 2024/0052383 A1Cargill, Incorporated
- Succinic acid production using issatchenkia16 Nov 2023US 2023/0365998 A1The Board of Trustees of the University of Illinois
Most cited
By later US patents
- Modulating the alternative complement pathway5US 8,937,046 B2The Regents of the University of Colorado, a body corporate · 2015
- Compositions and methods for succinate production3US 9,605,285 B2Cargill, Incorporated · 2017
- Yeast cells having reductive TCA pathway from pyruvate to succinate and overexpressing an exogenous NAD(P)+ transhydrogenase enzyme3US 9,850,507 B2Bioamber S.A.S. · 2017
- Recombinant codon optimised factor H2US 8,889,374 B2The University Court of the University of Edinburgh · 2014
- Regulator of complement activation and uses thereof2US 9,540,626 B2The Trustees of the University of Pennsylvania · 2017